At a glance
ClinicalIndex Comparison RecordN/ACompleted· 56 enrolled
Drug / intervention
GATT-Patchdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective, Multicenter, Single-arm, Clinical Investigation Evaluating the Safety and Performance of GATT-Patch for Hemostasis During Open Liver Surgery
In Brief
A clinical study evaluating GATT-Patch for Hemorrhage, Surgical. Completed, enrolled 56 participants across 3 sites.
Detailed Summary
The purpose of this study is to determine the clinical safety and performance of GATT-Patch for management of haemorrhage during elective open liver surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemorrhage, Surgical
CountriesNetherlands
CollaboratorsAvania
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMar 2021
Enrollment StartApr 2021
Primary CompletionJan 2022
Study CompletionFeb 2022
TodayJul 2026
First PostedMar 29, 2021
Enrollment StartApr 16, 2021
Primary CompletionJan 18, 2022
Study CompletionFeb 24, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.3 years ago
Interventions
GATT-Patchdevice
Use of GATT-Patch for minimal, mild or moderate bleeding sites in open liver surgery